BOSTON--(BUSINESS WIRE)--Point Therapeutics, Inc. (NASDAQ: POTP) today reported financial results for the fiscal quarter and six months ended June 30, 2007. Point reported a net loss of $3,282,000, or $0.08 per basic and diluted share, in the second quarter of 2007, compared with a net loss of $7,346,000, or $0.22 per basic and diluted share, in the second quarter of 2006. Point reported a net loss of $8,561,000, or $0.23 per basic and diluted share, in the first six months of 2007, compared with a net loss of $15,203,000, or $0.46 per basic and diluted share, for the first six months of 2006.
